{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:38:38Z","timestamp":1789958318336,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ijrobp.2023.03.066","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T21:01:46Z","timestamp":1680814906000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile Carcinoma"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6455-7452","authenticated-orcid":false,"given":"Sarah Rosanne","family":"Ottenhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hielke Martijn","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Doodeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerbert Lambertus","family":"Vrijenhoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten Lucas","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeantine Martina","family":"de Feijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Eline","family":"Schaake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Roberto","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel Simon","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris Jop","family":"Pos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.03.066_bib0001","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: Extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0002","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2013.02.037","article-title":"Early wound complications after inguinal lymphadenectomy in penile cancer: A historical cohort study and risk-factor analysis","volume":"64","author":"Stuiver","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0003","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fonc.2020.01521","article-title":"Importance of HPV in Chinese penile cancer: A contemporary multicenter study","volume":"10","author":"Gu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0004","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","article-title":"Population-based survival of penile cancer patients in Europe and the United States of America: No improvement since 1990","volume":"49","author":"Verhoeven","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.euf.2018.02.002","article-title":"Surgical and oncological outcomes in patients after vascularised flap reconstruction for locoregionally advanced penile cancer","volume":"5","author":"Ottenhof","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0006","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","article-title":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update","volume":"83","author":"Brouwer","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0007","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.urology.2010.03.082","article-title":"Bulky\/unresectable regional metastases of penile cancer","volume":"76","author":"Pettaway","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0008","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","article-title":"Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: Results of a multicenter analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0009","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2018.12.007","article-title":"Cancer of the anal region","volume":"135","author":"Valvo","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0012","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2009.01.004","article-title":"Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?","volume":"113","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.critrevonc.2016.04.004","article-title":"Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model","volume":"102","author":"Strigari","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canrad.2016.10.003","article-title":"Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine","volume":"21","author":"Lapierre","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","article-title":"The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer","volume":"36","author":"Yuan","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0016","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clgc.2014.03.009","article-title":"Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma","volume":"12","author":"Pond","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0017","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.clgc.2020.02.007","article-title":"Definitive chemoradiotherapy for locally advanced, lymph-node positive, nonmetastatic penile squamous cell carcinoma","volume":"18","author":"McComas","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0018","article-title":"Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma","volume":"2014","author":"Chhabra","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0019","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archdermatol.2009.160","article-title":"Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy","volume":"145","author":"Eliason","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000421-199312000-00009","article-title":"Combined modality therapy for locally advanced penile squamous cell carcinoma","volume":"16","author":"Pedrick","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0021","article-title":"Penile cancer with positive nodes: A case of HPV p16-positivity and its significance, implication of data from head and neck cancer","volume":"27","author":"Nguyen","year":"2019","journal-title":"Urol Case Reports"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0022","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.ijrobp.2012.12.008","article-title":"Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: A phase 1 study","volume":"85","author":"Deenen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0023","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.euf.2021.02.012","article-title":"F-18 fluorodeoxyglucose positron emission tomography with computed tomography has high diagnostic value for pelvic and distant staging in patients with high-risk penile carcinoma","volume":"8","author":"Ottenhof","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0025","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0026","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0","year":"2009"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0027","series-title":"Statistical Models and Methods for Lifetime Data","author":"Lawless","year":"1982"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0028","unstructured":"QIAGEN. QIAamp\u00ae DNA FFPE tissue handbook. Available at: https:\/\/www.qiagen.com\/nl\/resources\/resourcedetail?id=7d3df4c2-b522-4f6d-b990-0ac3a71799b6&lang=en. Accessed July 15, 2023."},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0029","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.juro.2014.07.105","article-title":"Combined chemoradiation as primary treatment for invasive male urethral cancer","volume":"193","author":"Kent","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","article-title":"DaPeCa-4: Outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation","volume":"54","author":"Maibom","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0031","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0032","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile Advanced Cancer Trial (InPACT): Rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"6_suppl","key":"10.1016\/j.ijrobp.2023.03.066_bib0033","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.6_suppl.TPS7","article-title":"The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases","volume":"40","author":"Pettaway","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0034","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/0284186X.2019.1634834","article-title":"Human papillomavirus, radiation dose and survival of patients with anal cancer","volume":"58","author":"Kabarriti","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0036","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2021.11.004","article-title":"Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study","volume":"164","author":"Woelber","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0037","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0038","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rpor.2019.09.006","article-title":"Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy","volume":"24","author":"Yuan","year":"2019","journal-title":"Reports Pract Oncol Radiother"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2023.03.066_bib0039","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.2967\/jnumed.108.057208","article-title":"PET monitoring of therapy response in head and neck squamous cell carcinoma","volume":"50","author":"Sch\u00f6der","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0040","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.116.185280","article-title":"Role of 18F-FDG PET\/CT in posttreatment evaluation of anal carcinoma","volume":"58","author":"Houard","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0041","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13139-013-0248-y","article-title":"The role of (18) F-FDG PET\/CT in assessing therapy response in cervix cancer after concurrent chemoradiation therapy","volume":"48","author":"Choi","year":"2014","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2023.03.066_bib0042","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:08:01Z","timestamp":1759745281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0360301623003103"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.03.066","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}